Cervical Cancer
📧 Sign up to get email alerts when something new happens for Cervical Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Women With Recurrent, or Metastatic Cervical Cancer [Phase 2]
Phase 2 trial update evaluating QL1706 plus chemotherapy with or without bevacizumab in first-line treatment for cervical cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer [Phase 2]
Phase 2 clinical trial exploring tislelizumab combined with bevacizumab and chemotherapy for persistent, recurrent, or metastatic cervical c…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Tachosil for the Prevention of Symptomatic Lymph Cysts [Phase 3]
Phase 3 trial update on Tachosil for prevention of symptomatic lymph cysts in gynecologic cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer [Phase 2]
Phase II study evaluating serplulimab plus bevacizumab with chemotherapy as first-line treatment for untreated recurrent or metastatic cervi…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors [Phase 2]
Phase 2 trial evaluating famitinib plus anti-PD1 therapy for advanced renal cell carcinoma, urothelial carcinoma, and gynecologic cancers su…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female [Phase 4]
Phase 4 trial update assessing lot consistency of recombinant HPV bivalent vaccine in healthy girls aged 9-14; study completed.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Trial to Optimally Show the Pharmacological Action of Z-100 [Phase 3]
Phase 3 trial assessing the pharmacological action of Z-100 for cervical cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Neoadjuvant Chemotherapy in Cervical Cancer [Phase 3]
A Phase 3 trial evaluating neoadjuvant chemotherapy in cervical cancer has completed accrual and status is completed.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial [Phase 3]
A randomized Phase III trial comparing neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone for stage IIIC cervic…
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy [Phase 2]
Phase 2 clinical study evaluating HLX10 with albumin-bound paclitaxel in advanced cervical cancer after progression or intolerance to first-…
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Promoting Cervical Cancer Screening Through the Advocacy of Screened Women [Phase 2]
Phase 2 clinical trial update focusing on promoting cervical cancer screening through advocacy by screened women.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer [Phase 2]
Phase 2 BrUOG 355 trial evaluating nivolumab with tailored radiation therapy and concurrent cisplatin in cervical cancer was terminated; res…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies [Phase 2]
Phase 2 clinical trial evaluating ScTILs (genetically modified tumor infiltrating lymphocytes) for cervical and ovarian cancers (and maligna…
-
CLINICAL_TRIALS trial_result · 2022-04-13Clinical Trial Update: PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer [Phase 2]
Phase 2 trial update evaluating PD-1 antibody with chemoradiotherapy for locally advanced cervical cancer (IB2-IIIB).
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers [Phase 1, Phase 2]
A Phase 1/2 trial update reports completed results for combining topotecan with the ATR inhibitor berzosertib (VX-970/M6620) in small cell c…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Tislelizumab and Radiotherapy for Recurrent Cervical Cancer [Phase 2]
A phase 2 clinical trial evaluating tislelizumab in combination with radiotherapy for recurrent/metastatic cervical cancer; current status a…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants [Phase 2]
Phase 2 trial update on the recombinant human papillomavirus nonavalent vaccine for preventing HPV infection in younger healthy participants…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Donafenib for Recurrent Cervical Cancer [Phase 2]
Phase 2 clinical trial update for donafenib in recurrent cervical cancer (includes various cervical cancer states and outcome considerations…
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive [Phase 1, Phase 2]
Phase 1/2 trial update on a T cell receptor therapy targeting MAGE-A3 in HLA-DP0401 positive metastatic cancer; study completed with posted …
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma [Phase 2]
Phase 2 trial update investigating Compound Kushen Injection combined with Pabolizumab for cervical cancer (cervical adenocarcinoma).
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy [Phase 2]
Phase 2 trial update evaluating immunotherapy for recurrent or persistent advanced cervical carcinoma refractory to platinum-based chemother…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: First-line Chemotherapy for Recurrent Cervical Cancer [Phase 2]
Phase 2 trial update for first-line chemotherapy in recurrent/persistent advanced cervical cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer [Phase 2]
Phase 2 clinical trial evaluating bupropion hydrochloride to improve sexual desire in women with breast or gynecologic cancers has completed…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer [Phase 3]
A Phase 3 randomized study evaluating Z-100 in combination with radiation therapy for cervical cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Image-Guided Gynecologic Brachytherapy [Phase 2]
Phase 2 clinical trial update for image-guided gynecologic brachytherapy in cervical and uterine cancers.